OncoCyte Ownership | Who Owns OncoCyte?
OncoCyte Ownership Summary
OncoCyte is owned by 13.94% institutional investors, 15.96% insiders, and 70.10% retail investors. Defender capital, llc. is the largest institutional shareholder, holding 0.67% of OCX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.92% of its assets in OncoCyte shares.
OCX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | OncoCyte | 13.94% | 15.96% | 70.10% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Defender capital, llc. | 55.22K | 0.67% | $162.90K |
| Awm investment company | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Defender capital, llc. | 55.22K | 0.06% | $162.90K |
| Awm investment company | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Defender capital, llc. | 55.22K | 0.06% | -665.00 |
| Awm investment company | - | - | -1.10M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Awm investment company | - | - | -1.10M |
| Defender capital, llc. | 55.22K | 0.06% | -665.00 |
Sold Out
| Holder | Change |
|---|---|
| Awm investment company | -1.10M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 2 | - | 1,152,395 | 42.24% | 13 | 12.44% | 1 | - | 1 | - |
| Mar 31, 2024 | 2 | - | 810,171 | -1.91% | 10 | 10.58% | - | -100.00% | 1 | - |
| Dec 31, 2023 | 2 | - | 825,936 | -0.94% | 10 | 9.42% | 1 | - | 1 | -50.00% |
| Sep 30, 2023 | 2 | -95.74% | 833,802 | -99.09% | 10 | 0.17% | - | -100.00% | 2 | -71.43% |
| Jun 30, 2023 | 47 | -7.84% | 91,824,895 | 64.98% | 77 | 3.53% | 19 | 216.67% | 7 | -61.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 154.88K | 0.92% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 85.00K | 0.50% | - |
| Fidelity Extended Market Index | 68.85K | 0.41% | -278.00 |
| iShares Micro-Cap ETF | 18.03K | 0.11% | - |
| NT Ext Equity Mkt Idx Fd - L | 11.96K | 0.09% | - |
| Northern Trust Extended Eq Market Idx | 11.96K | 0.09% | - |
| Fidelity Total Market Index | 12.25K | 0.07% | 5.69K |
| BlackRock Extended Equity Market K | 9.28K | 0.07% | -4.00 |
| Fidelity Series Total Market Index | 11.53K | 0.07% | 4.25K |
| NT Ext Equity Mkt Idx Fd - NL | 4.90K | 0.04% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 02, 2024 | James Andrea S. | Chief Financial Officer | Buy | $100.00K |
| Oct 02, 2024 | BROADWOOD PARTNERS, L.P. | - | Buy | - |
| Oct 02, 2024 | BROADWOOD PARTNERS, L.P. | - | Buy | $3.88M |
| Apr 11, 2024 | BROADWOOD PARTNERS, L.P. | - | Buy | - |
| Apr 11, 2024 | BROADWOOD PARTNERS, L.P. | - | Buy | $7.06M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 3 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | 4 | - |
| 2023 Q4 | - | - |
| 2023 Q3 | - | - |
OCX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools